Professor Department of Neurology / University of California Los Angeles / Goldberg Migraine Program Los Angeles, California, United States
This debate will consider prioritization of acute treatment options for migraine. Arguments against the use of gepants as ahead of triptans as acute migraine therapies will be presented.
Learning Objectives:
1. Describe the reasons that triptans should be used ahead of gepants in the acute treatment of migraine
2. Identify issues regarding efficacy, safety, and tolerability of acute treatments for migraine
3. Incorporate understanding of the different features of acute migraine therapies into clinical practice
